Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
New oncology biotech launches with $52M in its pocket
5 months ago
Financing
'It's the biology, stupid': Relation and GSK team up on fibrosis, osteoarthritis
5 months ago
Deals
AI
Belharra Therapeutics sticks with lead programs, trims workforce by 40%
5 months ago
People
Exclusive: Vijay Pande hands a16z biotech leadership to Vineeta Agarwala, moves to AI role
5 months ago
People
AI
Some research shows patients don’t stick with GLP-1s for long. Amazon Pharmacy and Ro say they're changing that
5 months ago
Pharma
Health Tech
Dimension nabs $500M second fund for 'still contrary' intersection of bio and machine learning
5 months ago
Financing
AI
Dutch biotech nabs €85M to position inflammatory antibody for a pharma buyer
5 months ago
Financing
BioAge Labs scraps Phase 2 obesity trial just months after IPO
5 months ago
R&D
GSK's third new pact of the week focuses on Alzheimer's with startup Muna Therapeutics
5 months ago
Deals
Pharma
Nuvig raises $161M as it prepares for Phase 2 study in hot autoimmune field
5 months ago
Financing
GSK partners with Rgenta on RNA-targeted small molecules for oncology, other areas
5 months ago
Deals
Pharma
Ro’s weight loss business more than doubled in the last year. Now it’s trying to prove its program works
5 months ago
Pharma
Health Tech
Dewpoint partners its ALS program, eyes JPM to raise a Series D
5 months ago
Deals
Pharma
On heels of MariTide data, Danish obesity biotech discloses €80M Series A
5 months ago
Financing
After deal about-face and a spinout, Maze assembles $115M Series D
5 months ago
Financing
Gilead makes another ADC move, inking up to $415M pact with Tubulis
5 months ago
Deals
Pharma
Acadia snaps up an essential tremor drug after field's summer setbacks
5 months ago
Deals
Food allergy biotech Alladapt closes after Phase 3 talks with FDA
5 months ago
R&D
Gilead buys experimental HIV vaccines from a small Barcelona biotech
5 months ago
Deals
Pharma
ADC biotech Adcendo nabs $135M Series B as it enters the clinic
5 months ago
Financing
Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas
5 months ago
Financing
Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January
5 months ago
Financing
Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy
5 months ago
Financing
Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagship
5 months ago
People
Pharma
First page
Previous page
4
5
6
7
8
9
10
Next page
Last page